Both in Pharmaceuticals
Disc Medicine vs Amylyx Pharmaceuticals
Over the past year IRON returned −6.2% and AMLX returned +107.2%; their daily moves had a correlation of 0.23.
IRON −6.2% AMLX +107.2%Growth of $1, one year, split-adjusted
| Metric | IRON | AMLX |
|---|---|---|
| Price | $80.84 | $28.86 |
| Market cap | $3.59B | $3.62B |
| Today | −2.41% | +0.63% |
| 1 month | +27.1% | +2.8% |
| 6 months | +20.8% | +80.3% |
| Year to date | +1.8% | +138.9% |
| 1 year | −4.9% | +107.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $658.4M | $250.8M |
| Dividend yield | — | — |
| Volatility (60d) | 75.7% | 112.7% |
| Short % of float | 22.8% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).